Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study
| Autor: | Schuler, A., Huser, J., Schmid, S., Schär, S., Scherz, A., Gautschi, O., Mauti, L., von Briel, T., Waibel, C., Wannesson, L., Pankovics, J., Mark, M.T., Rothschild, S.I., Addeo, A., Janthur, W.D., Siano, M., Boos, L., Britschgi, C., Früh, M. |
|---|---|
| Zdroj: | In Lung Cancer January 2024 187 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect